Moderna D
D
MRNA
48.570
USD
-0.19
(-0.39%)
مفتوح الان
حجم التداول
62,362
الربح لكل سهم
-7
العائد الربحي
-
P/E
-7
حجم السوق
19,156,536,761
Strategic Pips
منذ أسبوع
Strategic Pips
منذ 11 شهر
Strategic Pips
منذ سنتين
Strategic Pips
منذ سنتين
المزيد
الأخبار المقالات
العنوان: Moderna
القطاع: Healthcare
الصناعة: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.